反应条件
1.1: 1,8-diazabicyclo[5.4.0]undec-7-ene / 3.5 h / 140 - 160 °C
2.1: sodium hydroxide; ethanol
3.1: oxalyl dichloride / N,N-dimethyl-formamide / dichloromethane / 17 h / 0 - 20 °C
4.1: n-butyllithium / tetrahydrofuran; hexanes / -70 - -10 °C / Inert atmosphere
4.2: 3 h / -60 - 0 °C
View Scheme
参考文献
NEREUS PHARMACEUTICALS, INC.; YAMAZAKI, Yuri; HAYASHI, Yoshio
Patent: WO2011/84962 A1, 2011 ;